Correspondence on "sARS-CoV-2 vaccination in rituximab-treated patients: Evidence for impaired humoral but inducible cellular immune response" by Bonelli et al

Caoilfhionn Marie Connolly, Darya Koenig, Srekar N. Ravi, Antoine Azar, Sam Kant, Monika Dalal, Jessica Duchen, Philip Seo, Brendan Antiochos, Julie J. Paik, Duvuru Geetha

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article numbere164
JournalAnnals of the rheumatic diseases
Issue number10
StatePublished - Oct 1 2021


  • Covid-19
  • rituximab
  • systemic vasculitis
  • vaccination

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology
  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this